Literature DB >> 9576061

Gene structure, cDNA cloning, and expression of the rat cytokine-induced neutrophil chemoattractant-2 (CINC-2) gene.

F Shibata1, K Konishi, H Nakagawa.   

Abstract

Cytokine-induced neutrophil chemoattractant-2 (CINC-2) belongs to the CXC chemokine family and consists of two isoforms, CINC-2 alpha and CINC-2 beta. We have studied the genomic organization and expression of the CINC-2 gene. The gene spans approximately 14 kb and is composed of three common exons, one CINC-2 alpha-specific exon and two CINC-2 beta specific exons. This finding suggests that two isoforms of CINC-2 are encoded by mRNAs produced by alternative splicing. Each isoform is encoded in four exons, and exon-intron boundaries are placed identically within the aligned sequences of CXC chemokines. The CINC-2 alpha-specific exon encodes an extra C-terminal serine residue, in addition to three amino acid residues (DKS) which were determined from amino acid sequence analysis of CINC-2 alpha previously. The 5' flanking region of the gene contains a TATA box and putative binding sites for NF-kappa B and AP-1. Northern blot analyses showed that the mRNA level for CINC-2 was very low in rat peritoneal macrophages without stimulation and increased up to 4 h after lipopolysaccharide stimulation, similar to that for CINC-1 or CINC-3. Thereafter, the mRNA expression decreased gradually. However, the mRNA level of CINC-2 remained high 24 h after stimulation, in contrast to that of CINC-1 or CINC-3. These data indicate the expression of CINC-2 is regulated differently among the CINCs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576061     DOI: 10.1006/cyto.1997.0271

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  1 in total

1.  Expression of CINC-2beta is related to the state of differentiation of alveolar epithelial cells.

Authors:  Kahoru Nishina; Feijie Zhang; Larry D Nielsen; Karen Edeen; Jieru Wang; Robert J Mason
Journal:  Am J Respir Cell Mol Biol       Date:  2005-07-29       Impact factor: 6.914

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.